跳至主要内容
临床试验/NCT06341374
NCT06341374招募中不适用

Impact of Sleep Disorders on Innate Immunity in COVID-19 Patients. A Cohort Study

Parc Taulí Hospital Universitari1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年11月6日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
Immunological study: cytokines.

研究概览

简要总结

Sleep is an important modulator of the immune response, whereby sleep disturbances (ie, poor sleep quality, insufficient sleep and/or primary sleep disorder, obstructive sleep apnea (OSA)) contribute to inflammatory disease risk and dysregulation of immune response in front of infectious agents.

The objective of this study is to evaluate the impact of undiagnosed and non-treated sleep disorders on innate immunity in a cohort of COVID-19 patients and the role of trained immunity induced by influenza vaccination in the innate immune response.

详细描述

Sleep and immune system have reciprocal relationship. Sleep has a restorative role on immune system, influencing innate and adaptive immunity and sleep disorders can decrease immune response.

Healthy innate immunity is crucial into regulation of the response against SARS-CoV-2.

The hypothesis of the study is that the innate immunity response is blunted by sleep disorders and, this mitigated immune response, could influence on COVID-19 severity. Impaired immune response in patients with sleep disorders could be ameliorated inducing trained immunity by influenza vaccine.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants over 18 years old with diagnosis of COVID-19 during first year of coronavirus pandemic in March-June 2021.

排除标准

  • >70 years and <18 years
  • Recent COVID-19 (<6 months)
  • Other infection (<3 months)
  • Obstructive sleep apnea in treatment with CPAP prior to COVID infection.
  • Immunosuppressed

结局指标

主要结局

Immunological study: cytokines.

时间窗: To evaluate immune response blood samples will be taken at the time influenza vaccine is given, 7 and 30 days later.

To measure in blood: IL-1 beta, IL-6, IL-8, IL-10, TNF-alfa, IFN-alfa, IFN-gamma, GM-CSF.

次要结局

  • Epigenetic modification.(To evaluate immune response blood samples will be taken at the time influenza vaccine is given, 7 and 30 days later.)
  • Innate cells: monocytes, classical dendritic cells and Natural Killer cells.(To evaluate immune response blood samples will be taken at the time influenza vaccine is given, 7 and 30 days later.)
  • Diagnostic of obstructive sleep apnea in selected cohort(It is an overnight study that will last for one night.)

研究者

发起方
Parc Taulí Hospital Universitari
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrea Grau Freixinet

Pulmonology medical specialist

Parc Taulí Hospital Universitari

研究点 (1)

Loading locations...

相似试验